Determination of venlafaxine in human plasma by HPLC-fluorescence and bioequivalence of venlafaxine capsules
ZHANG Zhi-hua,HE Zhou-kang,ZHOU Yan-bin,LI Yu-hong,TIAN Juan,ZUO Ying,DING Jin-Song
2008-01-01
Abstract:Objective To develop an HPLC-fluorescence method to determine venlafaxine in plasma and to evaluate the bioequivalence of 2 venlafaxine capsules(T and R).Methods Venlafaxine was separated on a Diamonsil C18 column with a mixture of acetonitrile-phosphate buffer solution(25∶75,v/v,pH value was adjusted to 7.35 by H3PO4),as the mobile phase,and was detected at EX:276 nm,EM:598 nm,and the internal standard was lafutidine.A single oral dose of 100 mg venlafaxine was administered to 18 healthy volunteers in a randomized crossover study,and then the pharmacokinetics and bioavailability were studied.Results Venlafaxine was separated well with the endogenous substances.The calibration curve was linear at 5.1～490.7 μg·L-1 with r2= 0.999 8,the absolute recovery was 98.6%~100.5%(n=20),and the method recovery was 89.3%~108.7%(n=15),with inter-day RSD<3.6%(n=15) and intra-day RSD<9.6%(n=15).The AUC0~24 of the 2 capsules was(1 146.4±339.6)and 1 132.9±311.3)μg·h·L-1,Cmax was(167.7±49.1)and(177.6±47.8)μg·L-1,while tmax was(1.9±0.3) and(1.8±0.6)h.The relative bioavailability of capsule T was(103.7%±13.3%) as compared with capsule R.Conclusion The established method is accurate and sensible for the determination venlafaxine in human plasma.Statistic analysis showed no significant difference between the 2 capsules,and bioequivalence was observed.